NL-OMON41756已完成不适用
A single-center, open-label, two sequence, crossover study to investigate the interaction between Colistin Methansulfonate Sodium (CMS) and RO7033877 in healthy subjects. - RO7033877/Colistin Methanesulfonate Sodium (CMS) DDI study.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 28
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •healthy male or female
- •18 - 55 years of age, inclusive
- •BMI 18.0 - 30.0 kilograms/meter2
- •Weight 60 kg or more, but less than 100 kg
排除标准
- •Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of participation in another drug study within 90 days before the start of this study or being a blood donor within 60 days from the start of the study. In case of donating more than 1.5 liters of blood in the 10 months prior the start of this study.
研究者
相似试验
进行中（未招募）
1 期
Study to compare the pharmacokinetics of mometasone furoate alone and in combination with indacaterol in patients = 6 to < 12 years old with asthmaAsthma in pediatric patientsMedDRA version: 20.0Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2020-002036-78-HUovartis Pharma AG32
尚未招募
不适用
Effect of Multiple Oral Administration of Bacosides Enriched Standardized Extract of Bacopa (BESEB)(150 mg BD) on the Pharmacokinetics, Safety and Tolerability of Gliclazide 80mg and Metformin 500mg in Indian Patients With Type 2 Diabetes.CTRI/2016/08/007157CSIR Central Drug Research Institute24
进行中（未招募）
1 期
A study to evaluate whether it is safe for patients with pulmonary arterial hypertension to temporarily change from selexipag tablets (Uptravi®) to selexipag given directly into a vein (intravenous selexipag)Pulmonary arterial hypertensionMedDRA version: 20.0 Level: PT Classification code 10064911 Term: Pulmonary arterial hypertension System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2016-004035-21-DEActelion Pharmaceuticals Ltd20
已完成
1 期
To Evaluate the Effect of Multiple Dose Erythromycin on the Pharmacokinetics (action of drug in the body) of GRC 17536 After a Single Dose in Healthy Male Subjects.CTRI/2015/01/005417Glenmark Pharmaceuticals SA30
进行中（未招募）
1 期
A study to evaluate the safety, tolerability, processing by the body and mechanism of action of multiple doses of ralmitaront with a single dose of risperidone administered to healthy participantsSafety, tolerability, pharmacokinetics and pharmacodynamics of ralmitaront and risperidone in healthy participantsISRCTN14984258Roche (Switzerland)20